By: Dr. Shane Kurth, D.C., BCN
Founder & Head of Franchise Development, Radiant Results
Updated May 2026
This post covers what the current red light therapy market data actually shows — CAGR projections, demand drivers, regional breakdowns — and translates it into a practical framework for investors and operators. It’s written from inside the franchise, which means you’ll get analysis no market research firm can offer: what the data looks like when an actual location opens, not just what it looks like in a spreadsheet. If you’re past the “is this real?” question and into the “is this the right time?” question, this is the read.
The red light therapy market is growing at 12%+ CAGR through 2030 — and none of the $3,000–$8,000 institutional research reports explain what that means for a real operator making an entry decision. That’s what this post is for.
Most published forecasts are written for corporate buyers, not franchise operators. They cover total market size. They don’t answer the question that matters: what does a 12%+ CAGR mean for someone deciding whether to open a location in the next 12–24 months?
Key Takeaways
- According to Grand View Research and Fortune Business Insights, the global red light therapy market is projected to grow at a CAGR of approximately 12%+ through 2030, from a 2024 base estimated between $1.1B and $1.4B. Verify current figures against the most recent published editions of both reports before drawing conclusions.
- North America holds approximately 40% of global market share. This is driven by consumer wellness spending, athletic recovery adoption, and increasing clinical validation of photobiomodulation research.
- Most published market data covers device manufacturing and retail. The service-clinic segment — where franchise operators participate — is undercovered and represents the higher-margin side of the growth curve.
- Professional red light therapy clinic density in most U.S. metros remains near zero relative to measurable consumer demand. This is the defining characteristic of an early-stage, high-growth service category.
- Radiant Results’ Sandy, UT location recorded 400%+ growth in organic search impressions and 200%+ growth in clicks within the first 30 days of its SEO program. (These are marketing performance metrics — not financial performance indicators or revenue projections.)
Red Light Therapy Market Size: 2024 Baseline and 2026 Forecast
According to Grand View Research, the global photobiomodulation therapy market was valued at approximately $1.1B in 2023. It is projected to grow at a CAGR of roughly 12.2% through 2030. Fortune Business Insights publishes a comparable figure with a 2024–2032 forecast horizon, citing similar growth dynamics.
These figures vary across research firms because they draw market boundaries differently. Some reports include only consumer and clinical devices. Others incorporate broader photobiomodulation applications in physical therapy, dermatology, and sports medicine. A separate Grand View Research report on the red light therapy beds segment specifically projects that sub-market growing from $162.3 million in 2024 to $491.6 million by 2033 at an 11.9% CAGR — directionally consistent with the broader photobiomodulation figures.
For evaluating a red light therapy franchise investment, the precise total addressable market figure matters less than the directional consensus: multiple independent firms, using different methodologies, arrive at a double-digit CAGR over the same timeframe.
The table below illustrates the projected market trajectory at the 12% CAGR rate. These are directional projections based on published figures — not guarantees — and should be cross-referenced against the most current research at time of evaluation.
| Year | Projected Market Size (Est.) | YoY Growth at 12% CAGR |
|---|---|---|
| 2024 | ~$1.2B | — |
| 2025 | ~$1.34B | ~12% |
| 2026 | ~$1.50B | ~12% |
| 2027 | ~$1.68B | ~12% |
| 2028 | ~$1.88B | ~12% |
| 2029 | ~$2.11B | ~12% |
| 2030 | ~$2.37B | ~12% |
Source: Directional projections based on published CAGR figures from Grand View Research and Fortune Business Insights. Verify current base-year figures against the most recent published editions of both reports. These projections apply to the broader red light therapy and photobiomodulation market. The service-clinic segment is not separately quantified in current public research.
The device market and the service-clinic market are structurally different businesses. A consumer buying a $300 panel online and a membership holder visiting a professional clinic twice a week both contribute to the same headline market number. But they are not in the same market. The device retail segment is increasingly commoditized. The service-clinic segment — where franchise operators sit — is early-stage, fragmented, and underserved in most U.S. metros. That distinction is the most important one a prospective operator needs to understand, and I’ll return to it in detail below.
Why the Red Light Therapy Market Is Growing Faster Than Adjacent Wellness Categories
When a data-literate investor sees 12% CAGR, the first question is: is this a fad? It’s a fair question. Wellness franchise categories have ignited, peaked, and contracted within a decade before. The question deserves a data-driven answer.
Compare red light therapy’s projected CAGR against adjacent franchise categories that have followed a similar consumer adoption curve:
| Category | Estimated CAGR | Maturity Stage | Primary Consumer Driver |
|---|---|---|---|
| Red light therapy | ~12%+ (through 2030) | Early growth | Recovery, anti-aging, biohacking |
| Cryotherapy | ~7–9% | Mid-to-late maturity | Athletic recovery |
| IV therapy / hydration | ~8–10% | Mid maturity | Hangover recovery, performance |
| Float therapy | ~5–7% | Niche/stable | Stress, mindfulness |
| Med spa services | ~14–16% | Growth (broad category) | Aesthetics, multiple sub-segments |
Source: CAGR estimates compiled from IBISWorld, Grand View Research, and Fortune Business Insights published reports. Figures represent directional ranges across sources and publication years — verify current published figures before making investment decisions. Adjacent category figures may reflect broader wellness segments.
The cryotherapy comparison is instructive. Cryotherapy franchises expanded rapidly between 2014 and 2019 on the back of athlete endorsements and strong early consumer interest. Operators who entered early built defensible customer bases and local brand recognition. Operators who entered after 2019 found compressed territory availability, more established competition, and harder unit economics.
Red light therapy is at roughly the same point on the curve that cryotherapy was in 2015 — with one meaningful difference: its evidence base and consumer legitimacy are stronger.
The confidence that red light therapy is not a transient trend comes down to the underlying science. Photobiomodulation and mitochondrial function — the mechanism by which specific wavelengths of light interact with cellular energy production — is not a marketing claim. It is the subject of a growing peer-reviewed literature and the basis of multiple FDA clearances for photobiomodulation devices. A technology with a documented scientific mechanism and an active regulatory framework does not behave like a trend. It behaves like a category.
IBISWorld’s health and wellness sector data supports broader context: wellness service businesses are growing at a rate that consistently outpaces general consumer spending, driven by structural demographic and behavioral shifts covered in the next section.
The Five Demand Drivers Behind Current Red Light Therapy Growth
Understanding why the market is growing matters more than the CAGR number itself. The drivers below are the ones the Radiant Results model was built around — not because they’re interesting macro trends, but because they translate directly into session frequency, membership retention, and location-level demand in markets like Sandy, UT and Charlotte, NC.
Driver 1: Aging Population and Longevity Spending
According to the U.S. Census Bureau, the population aged 65 and older will exceed 73 million by 2030. This demographic is buying recovery, skin health, joint support, and energy — the specific wellness outcomes that drive high session frequency at professional light therapy clinics. Longevity-focused wellness spending is becoming a mainstream consumer category. It is structurally well-aligned with what a professional red light therapy clinic offers.
Driver 2: Athletic Recovery and Performance Mainstreaming
Three years ago, red light therapy was a fringe biohack among elite athletes. Today it is standard infrastructure at professional sports franchises and high-end fitness facilities. That mainstream adoption has a downstream effect on general fitness consumers who follow the same protocols their favorite athletes use. The fitness community is one of the most consistent early-adopter segments in every market we’ve entered. This is a demand-creation mechanism that franchisees benefit from before spending a dollar on direct advertising.
Driver 3: Biohacking and the Quantified-Self Consumer
The biohacking segment — consumers who track and optimize their physiology — is one of the most reliable high-frequency service customers in the wellness space. They return consistently because they are data-driven about results. This is precisely why Radiant Results locations include the Styku 3D body scanner. When a member can track measurable body composition changes over time, they do not cancel memberships. They increase session frequency and refer within their network. The Styku is a membership retention tool engineered for the consumer who demands evidence.
Driver 4: The Shift From Home Devices to Professional Services
Consumer-grade red light therapy devices are widely available at retail. Many people try them. The issue is that consumer devices typically deliver lower irradiance than clinical-grade equipment, and inconsistent output across small treatment areas. Consumers who start with a $400 panel and find results inconsistent do not abandon red light therapy — they seek professional alternatives. The Dahlia Full Body Light Therapy Bed in every Radiant Results location is medical-grade equipment delivering full-body treatment in 15-minute sessions. The contrast in output and experience creates a natural funnel from disappointed home-device users into professional clinic memberships. In a maturing category, the home device market becomes a lead generation asset for clinic operators.
Driver 5: Growing Clinical Legitimacy and Reduced Acquisition Friction
The expanding peer-reviewed photobiomodulation literature, combined with FDA clearance activity on specific device applications, creates a legitimacy signal that reduces consumer education burden on a franchise operator. Avci et al.’s 2013 review in Seminars in Cutaneous Medicine and Surgery is one of the most-cited works documenting therapeutic applications across multiple tissue types. When potential members arrive having already done their research, the sales process is shorter and the objection rate is lower.
To be precise: no treatment efficacy claims are made here. The directional movement toward category recognition in mainstream wellness contexts is a favorable signal for professional clinic operators building membership-based businesses.
Devices vs. Service Clinics: Where the Real Investor Opportunity Sits
This is the distinction most investors miss. Every market research report buries it or ignores it entirely. The $1.1B–$1.4B market figure cited across research reports is primarily measuring device manufacturing, consumer hardware retail, and clinical device sales to medical facilities. It is not measuring what happens when a franchise operator opens a professional clinic and sells memberships in a suburban market.
These are structurally different businesses:
| Dimension | Device / Retail Market | Service-Clinic / Franchise Market |
|---|---|---|
| Capital requirements | High (manufacturing or retail inventory) | Location-level buildout, equipment |
| Competitive density | High and increasing | Low — most markets unserved |
| Revenue model | Transactional / one-time purchase | Recurring membership |
| Gross margin profile | Compressed at retail level | Structurally higher on services |
| Inventory dependency | High | Low (~5% COGS at service level) |
| Franchise model fit | Poor | Strong |
| Customer acquisition | Retail channel dependent | Local market + referral driven |
Note: Service-clinic financial figures reference company-owned location performance as disclosed in Item 19 of the Radiant Results FDD. Specific margin and revenue figures should be evaluated in the context of the complete FDD. Do not interpret this table as a financial projection or guaranteed franchisee outcome.
The franchise/service-clinic segment is early-stage and fragmented in a way the device market is not. Most U.S. metropolitan markets — including many high-income suburban markets with strong wellness consumer bases — currently have zero professional red light therapy clinics. The first well-operated franchise location in one of those markets is not entering competition. It is creating a category. That dynamic will not persist indefinitely, which is precisely why the timing argument matters.
The International Franchise Association tracks wellness franchise sector data that positions health and wellness franchising as one of the strongest-performing categories in the broader franchise economy. The service-clinic model sits directly within that high-performing segment.
If this sounds like the kind of business you want to build, see if you qualify for a Radiant Results location. Markets are being selectively awarded — not every applicant is the right fit, and that’s intentional.
This is not a franchise offering. A franchise can only be offered through delivery of a Franchise Disclosure Document.
Regional Hotspots: U.S. Markets With the Highest Untapped Demand
According to Grand View Research, North America holds approximately 40% of the global red light therapy market share. The growth drivers — aging population, athletic recovery culture, high wellness consumer spending — are disproportionately concentrated in the U.S. But national-level market share data obscures the more actionable insight for an operator: demand is not evenly distributed, and professional supply is almost non-existent across most metros.
Radiant Results currently operates in Sandy, UT and Charlotte, NC (Uptown and Lake Norman), and is actively opening in St. Louis, MO. These markets were not selected randomly. They share a consistent profile: suburban high-income demographics, above-average health and wellness consumer spending, strong fitness and athletic community infrastructure, and limited to zero existing professional red light therapy competition at time of entry. That last factor is the one that drives early location economics.
The franchise territory selection framework focuses on factors that correlate with strong demand and favorable competitive positioning. The indicators that matter include:
- Population density within the primary trade area
- Household income and discretionary wellness spend
- Proximity to fitness infrastructure (gyms, athletic clubs, sport-specific training facilities)
- Existing wellness category penetration (massage, cryotherapy, med spa density as a proxy for willingness to pay for wellness services)
- Current absence of professional red light therapy competition
One consistent finding: the most attractive red light therapy markets are frequently not the top 10 largest metros. Suburban high-income markets with strong health consumer bases regularly outperform urban cores, where commercial lease costs compress margins before a location can build its membership base.
Proof of Concept: What the Sandy, UT Market Data Shows
When the Sandy, UT location opened, the question was simple: how quickly can a professional red light therapy clinic capture existing consumer demand in a market where none had previously existed? The first 30 days of the location’s SEO program provided the answer.
Sandy recorded 400%+ growth in organic search impressions and 200%+ growth in organic clicks within those first 30 days. To be precise: these are marketing performance metrics — organic search visibility and traffic data — not financial performance indicators, revenue projections, or profit claims. For financial performance data, refer to Item 19 of the Radiant Results FDD.
What the data does tell an investor is meaningful. A market generating consumer search activity for red light therapy — with no professional location present to capture it — responded immediately when a qualified provider entered. The growth curve was steep because the location was the first answer to active, existing consumer intent. There was no gradual demand-building phase. The demand was already there.
Sandy fits a specific market profile: suburban, high-income, health-conscious consumer base, strong fitness community, and a complete absence of professional red light therapy competition at entry. Dozens of U.S. markets share this profile and remain unserved. The Sandy result is not used to make income promises. It is a proof of concept for market dynamics: when a professional, well-equipped location enters a market with latent demand and no competition, that demand responds.
The Dahlia Full Body Light Therapy Bed is a material factor in this. Medical-grade equipment is a consumer trust signal. In a category where many consumers have had inconsistent experiences with lower-grade home devices, it creates meaningful differentiation. That differentiation drives both initial trial conversion and word-of-mouth referral in a new location’s early months.
What 12% CAGR Actually Means for an Operator Entering in 2026–2027
A 12% CAGR is a useful headline. It’s only actionable if you understand what it means for a specific operator making an entry decision in a specific market in a specific year.
At 12% CAGR, the red light therapy market will approximately double over the next six years. That doubling happens whether existing operators capture it or new entrants do. Operators who establish territory presence before that doubling arrives are positioned to grow with the market — building membership bases, accruing local SEO authority, and developing community relationships — rather than fighting for share in a market where those positions are already occupied.
The current entry window is specific. The next 12–24 months represent the period before professional red light therapy clinic density meaningfully increases in most U.S. metros. After that window closes — the way it closed in cryotherapy and IV therapy — the most attractive markets will have established operators. Those operators will have entrenched customer bases, years of local search authority, and referral networks that take 12–18 months to build from scratch. Investors who move in the current window will not be competing against those operators. They will be building them.
The “wait and see” objection is one cautious investors raise, and the instinct is understandable. But waiting does not reduce uncertainty about the market — it reduces competitive optionality within the market. Investors who waited for more certainty in cryotherapy before entering in 2019 entered a category that was simultaneously better understood and more saturated — more data, fewer available markets. That is the tradeoff “wait and see” produces in any high-growth wellness franchise category.
A franchise structure provides a mechanism for entering that window with infrastructure rather than starting from scratch. The medical-grade equipment, operational systems, territory selection framework, and marketing infrastructure are designed for exactly this kind of early-mover market entry. An independent operator can attempt the same entry — but they spend the first 18 months building what a franchisee receives on day one.
The Current Window: Evaluating Whether This Is the Right Entry Point
The data supports a clear thesis. The red light therapy market is in early-growth phase with a documented 12%+ CAGR, rising consumer demand across five distinct and durable driver categories, and near-zero professional clinic density in most U.S. markets. Strong macro growth, active consumer demand, and thin competitive supply define a favorable franchise entry window. It will not remain open indefinitely.
Radiant Results is actively expanding with locations in Sandy, UT, Charlotte, NC (Uptown and Lake Norman), and St. Louis, MO. These markets represent multiple demographic profiles, all confirming that the demand pattern seen in Sandy replicates across different U.S. metro types. The model is built for margin — approximately 87% gross margin on services, with roughly 92%+ of revenue from services, no inventory dependency, and lean staffing of 2–3 team members per location. For specific financial performance data, refer to Item 19 of the Radiant Results FDD. Company-owned location performance figures are disclosed there and should form the basis of any financial evaluation.
The operators who perform best in this model are active, systems-oriented, and relationship-focused. They are not looking for a hands-off asset, and they are not resistant to coaching. The qualification profile requires a net worth of $500K+ with $150K+ liquid capital and the operational commitment to build something real.
If you meet that profile, the next step is straightforward: evaluate whether your market is available.
See if you qualify for a location. Markets are being selectively awarded — not every applicant is the right fit, and that’s intentional.
This is not a franchise offering. A franchise can only be offered through delivery of a Franchise Disclosure Document.
FAQ: Red Light Therapy Market Growth, Franchise Investment, and Business Viability
How big is the red light therapy market in 2026?
According to Grand View Research and Fortune Business Insights, the global market was valued between approximately $1.1B and $1.4B in 2023–2024. At a 12%+ CAGR, the 2026 market estimate falls in the range of $1.5B–$1.7B across source methodologies. These figures cover the full market — devices, clinical hardware, and professional services. The service-clinic segment is not separately quantified in current public research. Verify current figures against the most recent published editions of both reports.
What is the projected CAGR for red light therapy through 2030?
Multiple independent research firms cite a CAGR in the range of 12%–14% through 2030. Grand View Research projects approximately 12.2%. Fortune Business Insights publishes a comparable figure on its 2024–2032 forecast horizon. For context, IBISWorld estimates the broader health and wellness services sector grows at approximately 5–7% annually — making red light therapy’s projected growth rate roughly twice the sector baseline. Confirm figures against current published report editions before making investment decisions.
Is the red light therapy industry still growing or is it saturated?
Saturation is segment-specific. The consumer device retail segment has higher competitive density — dozens of panel and device brands compete at retail price points. The professional service-clinic segment, where franchise operators participate, remains materially undersupplied in most U.S. markets. Most metros currently have zero professional red light therapy clinics. Device retail competition does not indicate clinic-level saturation. It often indicates the opposite: consumers who find consumer devices unsatisfying become strong clinic membership candidates.
What is driving red light therapy market growth?
Five structural drivers are creating sustained demand growth through the current decade. First, aging population: the U.S. 65+ demographic will exceed 73 million by 2030 per the U.S. Census Bureau, with recovery and longevity services among their fastest-growing wellness spend categories. Second, athletic recovery mainstreaming: professional sports adoption has normalized the modality with general fitness consumers. Third, biohacking culture: quantified-self consumers drive high session frequency and strong retention. Fourth, consumer device disappointment: under-delivering home devices funnel users toward professional services. Fifth, growing clinical legitimacy: an expanding base of peer-reviewed PBM research and FDA clearance activity reduce consumer acquisition friction for clinic operators. These are durable structural trends, not promotional cycles.
Where is red light therapy most popular in the United States?
North America holds approximately 40% of global market share according to Grand View Research. This is driven by consumer wellness spending patterns, athletic recovery culture, and high discretionary health spend. Demand is broadly distributed across high-income suburban markets with strong wellness consumer bases — not concentrated exclusively in major urban cores. Sandy, UT is a representative example: a suburban high-income market with strong fitness community infrastructure, showing high demand signals and low competitive friction at entry. Dozens of comparable markets across the U.S. currently have no professional red light therapy clinic presence.
Is red light therapy a good business to invest in?
The honest answer: it depends on market selection, operational commitment, and the quality of franchise support behind the model. The macro signals are favorable — a documented 12%+ CAGR in red light therapy market growth, active consumer demand, and near-zero professional clinic density in most markets. Those are meaningful tailwinds. But market timing alone does not make a business work. The operators who build strong locations in this category are active, systems-driven, and relationship-focused. They treat the franchise as an operating business, not a passive investment. For specific financial performance data on the Radiant Results model, Item 19 of the Franchise Disclosure Document is the appropriate reference — not projections or estimates from a blog post. Explore the Radiant Results franchise model to understand what’s included in the operator support structure.
